摘要
Neuroprotection in glaucoma can be thought of as a therapeutic paradigm for prophylaxis or prevention of death of retinal ganglion cells (RGCs) from injury, so as to maintain their physiological function. Death of RGCs is the final common pathway of all optic neuropathies, including glaucoma Although the actual mechanisms leading to retinal ganglion cell death in glaucoma are stillunclear, it is likely that they share features in common with
出处
《国际眼科杂志》
CAS
2003年第1期112-112,共1页
International Eye Science
